COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments

Scientists hypothesized that drugs such as ibuprofen or renin-angiotensin system (RAS) blockers could exacerbate the novel coronavirus disease COVID-19 by upregulating the angiotensin-converting enzyme 2 (ACE2), which serves as an entry receptor for the coronavirus SARS-CoV-2. This hypothesis was ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zolk, Oliver, Hafner, Susanne, Schmidt, Christoph Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225250/
https://www.ncbi.nlm.nih.gov/pubmed/32415494
http://dx.doi.org/10.1007/s00210-020-01890-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225250/
https://www.ncbi.nlm.nih.gov/pubmed/32415494
http://dx.doi.org/10.1007/s00210-020-01890-6

Ejemplares similares